MMMadhushika Mt

Madhushika Mt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Madhushika Mt has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cimetidine repurposed as a potential immunomodulatory agent against colorectal carcinoma: A systematic review

    by Wwm Gunasekara, Jlaa Sachindra, Mt Madhushika, Plgc Liyanage, S Lekamwasam

    Objective: To determine the survival benefit and immunomodulatory effects of cimetidine pre-, peri- or post-operatively in patients with colorectal cancer (CRC). Methods: A systematic review was conducted using PubMed and Cochrane Library to retrieve randomized control trials (RCTs) that investigated the effects of cimetidine on survival and immunomodulation via improvement in tumor infiltrating lymphocytes (TILs) and peripheral blood lymphocytes. The review was carried out in accordance with the extended Preferred Reporting Items for Systematic Reviews and Meta-analyses. Results: Four studies with the total of 267 patients were included in this systematic review. Treatment duration varied from 5 days to 1 year. Two studies reported a significant TIL response in the resected specimens after administering cimetidine, while one RCT showed an escalation of CD3, CD4 and CD57 lymphocytes in peripheral blood compared to the baseline following cimetidine treatment ( p < 0.01). Of the three trials that examined the effects of cimetidine on survival, only two studies revealed significant survival benefit while the remaining study only showed a trend towards survival benefit. Conclusion: Repurposing of existing drugs like cimetidine has a potential to offer a survival benefit by acting as an immunomodulatory agent in patients undergoing curative resection for CRC. However, the heterogeneity seen in current studies and the evolvement of adjunctive therapies for CRC warrant large-scale, well-designed prospective RCTs to establish the efficacy of cimetidine in CRC.


  • Prevalence, Characteristics and Factors Associated with Adverse Drug Reactions Among Hospitalized Patients

    by Madhushika Mt, Jayasinghe Ss, Liyanage Plgc, Sumanathilaka Tghk

    Objectives: This study aimed to describe the prevalence and characteristics of ADRs and to identify the factors associated with ADRs among hospitalized patients. Methodology: A descriptive cross-sectional study was conducted over a 6 month period at Teaching Hospital Karapitiya (THK), Sri Lanka. A total of 2000 patients, who were admitted consecutively for any type of treatment during the study period were enrolled. The factors associated with ADRs were evaluated using logistic regression models, using ADR occurrence as the outcome. Results: A total of 123 ADRs were found from the sample. The prevalence of ADRs among hospitalized patients was 6.2%. (95% CI 5.1-7.2). ADRs were reported in 62 males (50.4%). The median (IQR) age of ADR occurrence was 52 (35-67) years. The most prevalent type of ADR was Type A (n = 62, 50.4%) and out of the total ADRs, 74 were moderately severe reactions (60.2%). Antibiotics (n = 29, 23.5%) were the most common causative agent for ADRs, followed by anticoagulants (n = 10, 8.1%). The multivariate logistic regression model showed that the number of prescribed drugs ( P = .011), ADR history ( P = 0 0.01) and diabetes mellitus ( P = .003) were significantly associated with the occurrence of ADRs. Age ( P = .21), gender ( P = .31), ethnicity ( P = .14), and other concomitant illnesses (Hypertension P = .66, Ischemic Heart Disease P = .25, etc.) did not associated with the occurrence of ADRs. Conclusion: According to this study the prevalence of ADRs was significant among inward patients in the Teaching Hospital, Karapitiya. The number of prescribed drugs, ADR history and diabetes mellitus were significantly correlated with the occurrence of ADRs. The results of the study can be used to guide healthcare professionals to revise the medication list frequently and monitor the patients who are at risk for developing ADRs.


  • Open Access

    Evolution of Adverse drug reactions reporting systems: Paper-based to software-based

    by Thilini Madhushika, Thilak Weerarathna, Gayani Liyanage, Sudheera Jayasinghe

    Adverse Drug Reactions (ADR) add a significant clinical and economic burden to the healthcare system of a country. Reporting ADRs is the cornerstone of detecting uncommon ADRs once the drugs are on the market. In many countries, ADR reporting is regulated by national regulatory bodies and various methods are employed to report ADRs. Direct reporting by healthcare professionals has been adopted by many developed and developing countries. We present an overview of the different approaches of ADR reporting systems worldwide and their evolution over time.

  • Knowledge, Attitudes, and Practices of Adverse Drug Reaction Reporting Among Healthcare Professionals in Sri Lanka- A Cross Sectional Study

    by Menikpurage Thilini Madhushika, Sudheera Sammanthi Jayasinghe, Polwaththa Gayani Chandima Liyanage, Wellappuli Arachchige Dilan Malinda, Palitha Abeykoon

    Objectives: The objectives of this study were to describe the knowledge, attitudes and practices of Adverse Drug Reactions (ADR) reporting among healthcare professionals at Teaching Hospital Karapitiya (THK), a tertiary care hospital in Sri Lanka. Methodology: A descriptive cross-sectional study was conducted at THK. The healthcare professionals working in THK who were available during the study period were invited to the study. A self-administered pre-tested questionnaire was administered to the participants. Respondents were evaluated for their knowledge, attitudes and practices related to ADR reporting. The data were analyzed using SPSS statistical software. Results: Of the total 444 respondents, 31% were doctors and 69% were nurses. The majority of respondents, 90% (n = 400) were aware of the term ADR, while 64.8% (n = 288) could correctly define it. Among the respondents, 30.8% (n = 137) knew about the types of ADR and only 15.5% (n = 70) were able to mention a drug that is banned due to ADR correctly. Among the respondents, only 38.7% (n = 172) were aware of a formal process of reporting ADR and, only 35.3% (n = 157) stated that they had seen the ADR reporting form. Further, only 33.7% (n = 150) respondents have recognized ADR during their clinical practice and only a small proportion 18.2% (n = 81) have ever reported an ADR during their practice. Regarding attitudes toward ADR reporting, overall 84.1 (n = 373) had positive attitudes toward ADR reporting, while 13.54% (n = 60) of them stayed neutral and 2.25% (n = 10) had negative attitudes toward ADR reporting. Conclusions: Although the majority were aware of ADR , the knowledge and practices regarding spontaneous reporting of ADR are inadequate. However, most respondents have shown a positive attitude toward ADR reporting. A sincere and sustained effort should be made by concerned bodies to enhance the healthcare professionals’ knowledge, attitudes, and practices regarding ADR reporting.


  • Open Access

    Knowledge, attitudes and practices of Adverse Drug Reaction reporting among healthcare professionals in Teaching Hospital Karapitiya

    by Madhushika Mt, Ss Jayasinghe, Plgc Liyanage, Malinda Wad, P Abeykoon

    Objectives The objectives of this study were to describe the knowledge, attitudes and practices of Adverse Drug Reactions (ADR) reporting among healthcare professionals in Teaching Hospital Karapitiya (THK). Methodology A descriptive cross-sectional study was conducted at THK. The healthcare professionals working in THK who were available during the study period were invited to the study. A self-administered pre-tested questionnaire was given to the participants. Respondents were evaluated for their knowledge, attitudes and practices related to ADR reporting. The data was analyzed using SPSS statistical software. Results Of the total 444 respondents, 31% were doctors and 69% were nurses. Majority of respondents, 90% (n=400) were aware about the term ADR, while 64.8% (n=288) could correctly define it. Among the respondents, 30.8% (n=137) knew about the types of ADR and only 15.5% (n= 70) were able to correctly mention a drug that is banned due to ADR. Among the respondents, only 38.7% (n=172) were aware about formal process of reporting ADR and, only 35.3% (n=157) stated that they have seen ADR reporting form. Further, only 33.7% (n=150) respondents have recognized ADR in the practice and only a small proportion 18.2% (n=81) have ever reported an ADR during their practice. Regarding attitudes of ADR reporting, overall 84.1 (n=373) had positive attitude towards ADR reporting while 13.54% (n=60) of them stayed neutral and 2.25% (n=10) had negative attitude towards ADR reporting. Conclusions Although the majority was aware about ADR and the importance of their reporting, the knowledge and practices regarding the spontaneous reporting of ADR is inadequate. However, most of the respondents have shown a positive attitude towards ADR reporting. Sincere and sustained efforts should be made by concerned bodies to improve the knowledge, attitudes, and practices of health care professionals.

  • Evolution of adverse drug reactions reporting systems: paper based to software based

    by M. T. Madhushika, T. P. Weerarathna, P. L. G. C. Liyanage, S. S. Jayasinghe

    Objective Adverse Drug Reactions (ADR) add a significant clinical and economic burden to the healthcare system of a country. We present an overview of the different approaches of ADR reporting systems worldwide and their evolution over time. Methods A systematic review of the literature was made based on PubMed and the Cochrane database of systematic reviews. The articles searched for included original articles, WHO and FDA reports and institute of medicine reports. Summary Reporting ADRs is the cornerstone of detecting uncommon ADRs once the drugs are on the market. In many countries, ADR reporting is regulated by national regulatory bodies and various methods are employed to report ADRs. Direct reporting by healthcare professionals has been adopted by many developed and developing countries. With emerging new technologies in the field of medicine, there is a great potential to develop better ADR reporting systems in the countries where they have poor reporting. Conclusion Development and acquisition of newer technologies to promote ADR monitoring and reporting is a necessity for an effective pharmacovigilance system in a country.